Multiomics Market worth $5.70 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Aug. 6, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Multiomics Market is projected to reach USD 5.70 billion by 2031 from USD 3.18 billion in 2026, at a CAGR of 12.3% during the forecast period.

Browse 976 market data Tables and 476 Figures spread through 245 Pages and in-depth TOC on 'Multiomics Market- Global Forecast to 2031'

Multiomics Market Size & Forecast:

• Market Size Available for Years: 2026–2031
• 2026 Market Size: USD 3.18 billion
• 2031 Projected Market Size: USD 5.70 billion
• CAGR (2026–2031): 12.3%

Multiomics Market Trends & Insights:

• The global multiomics market is expanding steadily, driven by growing demand for integrated biological data analysis, increasing investments in precision medicine and biopharmaceutical research, and rising adoption of genomics, transcriptomics, proteomics, epigenomics, and spatial omics technologies across drug discovery, biomarker identification, disease research, clinical research, and translational applications.
• North America accounted for the largest market share of 44.2% in 2025.
• By offering, the products segment accounted for the largest market share of 43.4% in 2025.
• By method, spatial omics is the fastest-growing segment, growing at a CAGR of 13.8% during the forecast period.
• By technology, sequencing accounted for the largest share of 37.5% in 2025 and is projected to register the highest CAGR of 13.2% during the forecast period.
• Pharmaceutical & biotechnology companies dominated the market, accounting for 44% of the market in 2025.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213195527

The growth of the multiomics market is driven by the increasing accessibility of high-quality, integrated omics data for research. Additionally, AI, machine learning, and cloud bioinformatics are improving cross-omics interpretation, which is expected to support market growth.

The sequencing & analysis/sample characterization segment accounted for the largest share of the global multiomics market, by workflow, in 2025.

Based on workflow, the multiomics market is segmented into sample preparation, sequencing & analysis/sample characterization, and data visualization & analysis. The sequencing & analysis/sample characterization segment dominated the market in 2025, driven by the widespread adoption of next-generation sequencing (NGS), high-resolution mass spectrometry, single-cell sequencing, and spatial omics technologies for comprehensive molecular profiling. Increasing demand for integrated genomic, transcriptomic, proteomic, metabolomic, and epigenomic analyses in biomarker discovery, precision medicine, drug development, and translational research continues to support segment growth. Additionally, continuous advancements in sequencing platforms, mass spectrometry systems, and high-throughput analytical technologies have improved data quality, throughput, and scalability, reinforcing the segment's leading position in the global multiomics market.

Sequencing technologies are estimated to be the fastest-growing type segment in the multiomics market.

Based on technology, the multiomics market is segmented into sequencing, proteomics technologies, and other technologies. The sequencing technologies segment dominated the market in 2025 due to the widespread adoption of next-generation sequencing (NGS) for integrated genomic, transcriptomic, epigenomic, and single-cell analyses. Continuous advancements in sequencing accuracy, throughput, and cost efficiency, coupled with increasing applications in biomarker discovery, precision medicine, population genomics, and translational research, have accelerated technology adoption. Furthermore, the growing use of long-read sequencing, spatial transcriptomics, and multiomic sequencing platforms capable of simultaneously analyzing multiple molecular layers has reinforced the segment's leading position in the global multiomics market.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=213195527

North America accounted for the largest regional share in the global multiomics market in 2025.

The multiomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. In 2025, North America accounted for the largest share of the global multiomics market, driven by the presence of a well-established biotechnology and pharmaceutical ecosystem, strong investments in genomics and precision medicine research, and early adoption of advanced multiomics technologies. The region benefits from significant government and institutional funding for life sciences research, extensive adoption of next-generation sequencing (NGS), single-cell omics, and spatial omics platforms, and a strong presence of leading technology providers and academic research institutions. Additionally, increasing applications of multiomics in oncology, biomarker discovery, drug discovery and development, and personalized medicine continue to support the region's dominant market position.

Key Players

Leading players in the Multiomics companies include 10x Genomics, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Bruker Corporation (US), Agilent Technologies, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213195527

Browse Adjacent Market: Biotechnology Market Research Reports & Consulting

See More Latest Biotechnology Reports:

Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagents, Services (Core, Bioinformatics), Software, Workflow (Sample Prep, Separation), Applications, End User, Competition - Global Forecast to 2031

Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Global Forecast to 2031

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/multiomics-companies.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/multiomics.asp